The current price of SAUD3.SA is R$15.08 — it has increased by 1.89% since the previous close. Data as of Nov 6, 2026.
SAUD3.SA is up 2.94% over the past week, down 5.45% over the past month and up 25.88% over the past year. The price is above its 200-day moving average of R$14.07.
Of the 12 analysts covering Bradsaude S.A., 3 rate it a strong buy, 8 rate it a buy and 1 rates it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Bradsaude S.A. has a market capitalization of R$44.09B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Bradsaude S.A. posted earnings of R$0.3538 per share against an estimate of R$0.3233, beating expectations by 9.43%. Upcoming reports are listed in the earnings calendar.
Bradsaude S.A. reported revenue of R$13.52B in its most recent quarter, which has increased by 2,144.26% compared with the same quarter a year earlier. Analysts had expected R$14.62B.
Yes. Bradsaude S.A. pays dividends monthly. The latest payment of R$0.3421 per share has a payment date of Mar 30, 2027, which corresponds to a dividend yield of 5.38%.
Companies most comparable to Bradsaude S.A. include Hapvida Participações e Investimentos S.A. and Qualicorp Consultoria e Corretora de Seguros S.A.
In the latest trading session SAUD3.SA moved between R$14.72 and R$15.18, a range of 3.05% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Bradsaude S.A. shows a buy rating today and a strong buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks SAUD3.SA has traded between R$10.39 and R$16.57. The current price is 8.99% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.